bf/NYSE:EBS_icon.jpeg

NYSE:EBS

Emergent BioSolutions Inc.

  • Stock

USD

Last Close

8.91

30/08 20:00

Market Cap

487.34M

Beta: 0.93

Volume Today

9.83M

Avg: 1.88M

PE Ratio

−0.10

PFCF: −0.40

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
14.90M
-
40.16M
169.48%
71.31M
77.56%
75.47M
5.84%
108.41M
43.64%
174.31M
60.79%
214.15M
22.86%
264.75M
23.63%
328.90M
24.23%
351.30M
6.81%
340.35M
3.12%
average payables
29.41M
-
34.23M
16.38%
43.45M
26.95%
40.31M
7.23%
38.20M
5.23%
61.23M
60.28%
87.75M
43.32%
115.45M
31.57%
132.50M
14.77%
116.20M
12.30%
107.85M
7.19%
average receivables
81.14M
-
63.21M
22.09%
93.77M
48.33%
137.91M
47.08%
147.28M
6.80%
208.59M
41.63%
273.20M
30.97%
253.10M
7.36%
252.80M
0.12%
216.55M
14.34%
174.70M
19.33%
book value per share
13.52
-
14.81
9.53%
17.10
15.44%
14.84
13.24%
21.82
47.05%
20.18
7.52%
21.14
4.75%
27.46
29.91%
30.26
10.21%
27.60
8.78%
12.68
54.06%
capex per share
-1.16
-
-0.82
29.24%
-1.16
41.36%
-1.90
63.44%
-1.31
30.91%
-1.44
9.76%
-1.69
17.25%
-2.68
58.56%
-4.21
57.19%
-2.31
45.04%
-1.13
51.07%
capex to depreciation
-2.22
-
-0.95
57.36%
-1.27
34.18%
-1.99
57.29%
-1.29
35.44%
-1.16
10.00%
-0.79
32.28%
-1.23
56.87%
-1.82
47.59%
-0.81
55.54%
-0.46
42.73%
capex to operating cash flow
-0.43
-
-0.27
36.98%
-1.01
269.09%
-1.43
41.45%
-0.26
81.52%
-1.72
554.80%
-0.46
73.20%
-0.26
43.09%
-0.70
166.37%
3.40
584.63%
0.28
91.74%
capex to revenue
-0.13
-
-0.07
49.29%
-0.09
25.79%
-0.16
82.01%
-0.10
37.34%
-0.09
5.73%
-0.08
14.74%
-0.09
15.38%
-0.13
38.45%
-0.10
17.69%
-0.06
46.59%
cash per share
4.95
-
7.51
51.62%
8.10
7.90%
6.76
16.63%
4.26
36.90%
2.24
47.47%
3.26
45.49%
11.79
261.83%
10.77
8.66%
12.83
19.11%
2.18
82.99%
days of inventory on hand
86.03
-
202.44
135.31%
225.93
11.60%
205.74
8.93%
266.35
29.46%
233.07
12.50%
187.34
19.62%
213.85
14.15%
169.03
20.96%
185.10
9.51%
155.75
15.86%
days payables outstanding
161.69
-
126.17
21.97%
134.98
6.99%
96.33
28.63%
77.87
19.17%
91.39
17.37%
79.82
12.66%
94.80
18.77%
62.11
34.48%
54.46
12.32%
53.13
2.44%
days sales outstanding
77.31
-
48.81
36.87%
88.91
82.16%
110.87
24.71%
95.07
14.26%
126.47
33.03%
90.85
28.16%
54.18
40.36%
55.93
3.22%
51.58
7.78%
66.44
28.81%
debt to assets
0.14
-
0.31
119.46%
0.28
7.87%
0.28
2.62%
0.05
81.01%
0.36
579.08%
0.35
2.28%
0.30
12.89%
0.28
6.33%
0.44
56.20%
0.47
6.28%
debt to equity
0.18
-
0.53
193.00%
0.45
14.75%
0.45
0.22%
0.06
86.31%
0.79
1,176.72%
0.75
5.18%
0.60
18.89%
0.52
14.08%
1.02
95.68%
1.32
30.33%
dividend yield
earnings yield
0.04
-
0.04
3.42%
0.04
12.69%
0.04
3.63%
0.04
8.33%
0.02
50.33%
0.02
7.09%
0.06
229.40%
0.10
53.66%
-0.38
480.97%
-6.19
1,536.23%
enterprise value
714.93M
-
987.40M
38.11%
1.48B
50.33%
1.32B
11.33%
1.78B
35.11%
3.65B
105.37%
3.42B
6.31%
4.98B
45.40%
2.59B
47.93%
1.35B
47.70%
871.38M
35.69%
enterprise value over ebitda
11.47
-
10.53
8.19%
11.28
7.08%
12.32
9.24%
14.20
15.27%
31.38
120.94%
15.11
51.85%
9.00
40.45%
5.04
44.03%
-39.39
882.08%
-12.19
69.06%
ev to operating cash flow
7.37
-
8.79
19.24%
33.39
279.79%
24.61
26.30%
8.54
65.28%
87.38
922.64%
18.20
79.17%
9.28
49.00%
8.07
13.09%
-39.73
592.49%
-4.22
89.37%
ev to sales
2.29
-
2.19
4.04%
2.84
29.44%
2.69
5.16%
3.17
17.75%
4.67
47.23%
3.09
33.72%
3.20
3.39%
1.45
54.83%
1.21
16.35%
0.83
31.30%
free cash flow per share
1.52
-
2.19
44.04%
-0.01
100.42%
-0.57
6,095.40%
3.67
747.02%
-0.60
116.50%
1.96
424.59%
7.50
281.81%
1.80
76.03%
-2.99
266.57%
-5.16
72.46%
free cash flow yield
0.07
-
0.08
21.61%
-0.00
100.28%
-0.02
7,448.05%
0.08
557.24%
-0.01
112.93%
0.04
456.66%
0.08
129.89%
0.04
50.60%
-0.25
713.10%
-2.15
748.67%
graham net net
2.73
-
-0.90
132.92%
1.64
282.08%
1.14
30.14%
4.82
321.07%
-15.97
431.57%
-14.67
8.17%
-9.26
36.83%
-7.15
22.83%
-16.89
136.29%
-14.74
12.76%
graham number
16.18
-
18.11
11.93%
25.04
38.25%
20.74
17.16%
31.14
50.14%
23.84
23.45%
22.43
5.89%
59.80
166.59%
54.21
9.36%
52.67
2.83%
65.10
23.59%
income quality
3.20
-
3.06
4.61%
0.71
76.87%
1.03
46.08%
2.52
143.94%
0.67
73.55%
3.45
417.43%
1.76
49.07%
1.39
20.84%
0.15
89.04%
0.27
78.04%
intangibles to total assets
0.14
-
0.19
37.46%
0.15
21.30%
0.08
47.97%
0.16
104.29%
0.48
204.79%
0.43
9.72%
0.32
25.66%
0.28
13.07%
0.30
6.68%
0.31
3.92%
interest coverage
7.05
-
14.72
108.97%
13.85
5.91%
18.86
36.14%
9.07
51.90%
2.97
67.24%
13.86
366.43%
10.22
26.26%
-4.45
143.54%
-2.24
49.74%
interest debt per share
2.43
-
8.02
229.99%
7.84
2.19%
6.86
12.51%
1.50
78.13%
16.06
969.92%
16.50
2.75%
17.19
4.21%
16.36
4.82%
28.80
76.02%
18.52
35.71%
inventory turnover
4.24
-
1.80
57.50%
1.62
10.40%
1.77
9.81%
1.37
22.75%
1.57
14.28%
1.95
24.41%
1.71
12.39%
2.16
26.51%
1.97
8.68%
2.34
18.85%
invested capital
0.18
-
0.53
193.00%
0.45
14.75%
0.45
0.22%
0.06
86.31%
0.79
1,176.72%
0.75
5.18%
0.60
18.89%
0.52
14.08%
1.02
95.68%
1.32
30.33%
market cap
832.27M
-
1.02B
22.18%
1.54B
51.85%
1.32B
14.54%
1.94B
47.25%
2.97B
52.84%
2.78B
6.45%
4.72B
69.95%
2.33B
50.75%
591.68M
74.56%
122.88M
79.23%
net current asset value
135.65M
-
40.11M
70.43%
155.04M
286.49%
136.31M
12.08%
327.53M
140.28%
-597.70M
282.49%
-554.60M
7.21%
-240.30M
56.67%
-67.90M
71.74%
-572.90M
743.74%
-494.40M
13.70%
net debt to ebitda
-1.88
-
-0.31
83.29%
-0.45
44.38%
-0.03
92.96%
-1.32
4,013.32%
5.86
545.37%
2.84
51.54%
0.46
83.86%
0.51
12.34%
-22.19
4,408.23%
-10.47
52.81%
net income per share
0.86
-
0.98
14.39%
1.63
65.57%
1.29
20.90%
1.98
53.29%
1.25
36.64%
1.06
15.44%
5.79
447.07%
4.32
25.45%
-4.47
203.50%
-14.85
232.51%
operating cash flow per share
2.68
-
3.01
12.28%
1.15
61.70%
1.33
15.55%
4.98
273.95%
0.83
83.24%
3.65
337.53%
10.17
178.61%
6.00
40.99%
-0.68
111.34%
-4.03
491.99%
payables turnover
2.26
-
2.89
28.16%
2.70
6.53%
3.79
40.12%
4.69
23.71%
3.99
14.80%
4.57
14.50%
3.85
15.80%
5.88
52.64%
6.70
14.05%
6.87
2.50%
receivables turnover
4.72
-
7.48
58.39%
4.11
45.10%
3.29
19.81%
3.84
16.63%
2.89
24.83%
4.02
39.20%
6.74
67.68%
6.53
3.12%
7.08
8.43%
5.49
22.37%
research and ddevelopement to revenue
0.38
-
0.34
12.62%
0.29
12.09%
0.22
24.79%
0.17
21.63%
0.18
5.12%
0.20
12.06%
0.15
26.28%
0.13
13.42%
0.17
31.91%
0.11
38.34%
return on tangible assets
0.06
-
0.05
16.82%
0.07
47.69%
0.06
18.24%
0.09
58.42%
0.05
40.91%
0.04
23.67%
0.16
277.95%
0.11
30.58%
-0.10
192.99%
-0.61
500.23%
revenue per share
8.64
-
12.05
39.52%
13.55
12.38%
12.16
10.20%
13.41
10.27%
15.62
16.43%
21.48
37.52%
29.51
37.43%
33.51
13.53%
22.37
33.23%
20.49
8.40%
roe
0.06
-
0.07
4.44%
0.10
43.42%
0.09
8.83%
0.09
4.25%
0.06
31.49%
0.05
19.27%
0.21
321.12%
0.14
32.36%
-0.16
213.46%
-1.17
623.80%
roic
0.05
-
0.05
7.93%
0.07
47.76%
0.08
9.37%
0.09
16.13%
0.04
57.17%
0.04
10.52%
0.14
231.03%
0.11
24.80%
-0.06
157.08%
-0.14
125.44%
sales general and administrative to revenue
0.28
-
0.27
2.89%
0.28
4.06%
0.29
3.52%
0.26
12.97%
0.26
1.16%
shareholders equity per share
13.52
-
14.81
9.53%
17.10
15.44%
14.84
13.24%
21.82
47.05%
20.18
7.52%
21.14
4.75%
27.46
29.91%
30.26
10.21%
27.60
8.78%
12.68
54.06%
stock based compensation to revenue
0.04
-
0.03
20.69%
0.03
6.37%
0.04
24.70%
0.03
28.25%
0.03
9.32%
0.02
18.59%
0.03
35.82%
0.02
27.87%
0.04
70.12%
0.02
45.29%
tangible asset value
403.26M
-
375.07M
6.99%
505.24M
34.70%
521.34M
3.19%
743.62M
42.64%
-60.40M
108.12%
78M
229.14%
517.20M
563.08%
789.50M
52.65%
436M
44.78%
82.70M
81.03%
tangible book value per share
11.14
-
10.04
9.84%
13.09
30.34%
12.97
0.89%
17.78
37.07%
-1.21
106.78%
1.51
225.63%
9.81
547.98%
14.76
50.37%
8.70
41.03%
1.62
81.44%
working capital
216.46M
-
339.24M
56.72%
439.00M
29.41%
404.36M
7.89%
385.32M
4.71%
420.40M
9.10%
469.90M
11.77%
811.40M
72.68%
898.30M
10.71%
-19.20M
102.14%
28.20M
246.88%

All numbers in USD (except ratios and percentages)